Get started
Author

Takuto Tachita

Flotillin is a Novel Diagnostic Blood Marker of Alzheimer’s Disease
2019 · Mohammad Abdullah, Noriyuki Kimura, et al. · Journal of Alzheimer s Disease · 36
Expression, mutation, and methylation of cereblon‐pathway genes at pre‐ and post‐lenalidomide treatment in multiple myeloma
2020 · Takuto Tachita, Shiori Kinoshita, et al. · Cancer Science · 27
PDF
Exophiala dermatitidis Fungemia Diagnosed Using Time-of-flight Mass Spectrometry during Chemotherapy for Malignant Lymphoma and Successful Treatment with Voriconazole
2019 · Takashi Yoshida, Takuto Tachita, et al. · Internal Medicine · 14
PDF
Expression analysis of two SLAM family receptors, SLAMF2 and SLAMF7, in patients with multiple myeloma
2019 · Reham Ashour, Masaki Ri, et al. · International Journal of Hematology · 13
Newly diagnosed extranodal NK/T-cell lymphoma, nasal type, at the injected left arm after BNT162b2 mRNA COVID-19 vaccination
2023 · Takuto Tachita, Takenori Takahata, et al. · International Journal of Hematology · 11
PDF
Influence of CYP3A5 and ABCB1 polymorphisms on the pharmacokinetics of vincristine in adult patients receiving CHOP therapy
2023 · Junichi Nakagawa, Takenori Takahata, et al. · Cancer Chemotherapy and Pharmacology · 9
Aberrant tryptophan metabolism leads to unfavorable outcomes in lenalidomide‐treated myeloma patients
2022 · Arisa Asano, Masaki Ri, et al. · Hematological Oncology · 8
Impact of chromosomal abnormalities on the efficacy of lenalidomide plus dexamethasone treatment in patients with relapsed/refractory multiple myeloma
2019 · Takashi Yoshida, Masaki Ri, et al. · International Journal of Hematology · 6
Influence of Polymorphisms in Pharmacokinetics-Related Genes on the Areas Under the Plasma Concentration-Time Curves of Doxorubicin and Doxorubicinol in Patients with Diffuse Large B-Cell Lymphoma Receiving CHOP Therapy
2025 · Keigo Saito, Takenori Takahata, et al. · European Journal of Drug Metabolism and Pharmacokinetics · 5
Genomic analysis of multiple myeloma using targeted capture sequencing in the Japanese cohort
2020 · Takashi Kanamori, Masashi Sanada, et al. · British Journal of Haematology · 5
PDF
Comprehensive analysis of serum cytokines in patients with multiple myeloma before and after lenalidomide and dexamethasone
2024 · Takuto Tachita, Masaki Ri, et al. · Cancer Medicine · 4
PDF
VEXAS syndrome with eosinophilia and pathologically mimicking histiocytosis: a case report
2025 · Yasuhisa Murai, Rina Watanabe, et al. · Modern Rheumatology Case Reports · 2
PDF
Volunteer unrelated donor cell‐derived acute myeloid leukemia with RUNX1‐RUNX1T1
2021 · Shinya Hagiwara, Shigeru Kusumoto, et al. · eJHaem · 2
PDF
P4-3 An experience of pola-R-CHP regimen for DLBCL patients at our hospital
2024 · T. Takahata, E. Sato, et al. · Annals of Oncology · 1
The prognostic impact of CDH1 and MEG3 methylation status in multiple myeloma
2026 · Satoru Yamashita, Takuto Tachita, et al. · International Journal of Hematology
Effects of long-term cryopreservation at −80 °C on the viability and recovery of peripheral blood stem cells
2026 · Tomoaki Akagi, Toru Ebina, et al. · Hematology
PDF
A Simplified Limited-Sampling Strategy for Accurate Prediction of Doxorubicin and Doxorubicinol Exposure
2026 · Keigo Saito, Takenori Takahata, et al. · Therapeutic Drug Monitoring
Multiple myeloma with ≥1% circulating plasma cells in peripheral blood has a poor prognosis
2025 · Kosuke Miki, Koh Izumiyama, et al. · Blood
P65-1 Clinicopathological feature of T-cell lymphoma in our institute
2022 · Takenori Takahata, Takuto Tachita, et al. · Annals of Oncology
PDF
Analysis of serum cell free DNA in patients with multiple myeloma
2019 · Takuto Tachita · The Japanese Society of Hematology
Detection of IGH translocations in multiple myeloma using next generation sequencing
2019 · Takashi Kanamori, Masashi Sanada, et al. · The Japanese Society of Hematology
Pf572 Analyses of Expression Levels, Mutations, and Methylation Status of Crbn‐related Genes Pre‐ and Post‐lenalidomide Treatment in Multiple Myeloma
2019 · T. Tachita, S. Kinoshita, et al. · HemaSphere
Pb1942 Does Stepwise Dose Escalation Method of Nilotinib for Cml Improve Mr4.5 and Treatment Free Remission?
2019 · K. Mayama, K. Yamaguchi, et al. · HemaSphere
Ps1367 Comprehensive Genetic Analysis of Multiple Myeloma in Japan
2019 · T. Kanamori, M. Sanada, et al. · HemaSphere
Not all patients with CCND1-positive multiple myeloma show favorable outcome even with novel agents
2018 · Takuto Tachita · The Japanese Society of Hematology
Works count: 25
Citation count: 143
H-index: 7
I10-index: 5
Year
Topic
Type